Skip to main content

Table 1 Demographic and Clinical Characteristics of Diabetes Cohort and Drug Treatment Categories*,†

From: Barriers to self-monitoring of blood glucose among adults with diabetes in an HMO: A cross sectional study

 

Managed Without Drugs (n = 1,346)

Insulin-Managed (n = 1,428

Oral Sulfonylurea-Managed (n = 1,791)

Characteristics

N

(%)

N

(%)

N

(%)

Gender

      

   Male

600

(44.6)

697

(48.8)

1,003

(56.0)

   Female

746

(55.4)

731

(51.2)

788

(44.0)

Mean Age

52 ± 14.2

51 ± 14.1

56 ± 12.3

Race

N

(%)

N

(%)

N

(%)

   White

747

(75.5)

652

(65.6)

814

(68.5)

   Black

180

(18.2)

305

(30.7)

300

(25.2)

   Other

62

(6.3)

37

(3.7)

75

(6.3)

   Missing

357

---

434

---

602

---

Eligibility

      

   Medicaid

17

(1.3)

10

(0.7)

7

(0.4)

   Medicare

238

(17.8)

242

(17.2)

420

(23.7)

   Commercial

1,079

(80.9)

1,159

(82.1)

1,345

(75.9)

   Missing

12

---

17

---

19

---

Body Mass Index

      

   Underweight

13

(1.2)

13

(1.1)

11

(0.8)

   Normal

220

(19.5)

249

(21.2)

201

(13.9)

   Overweight

370

(32.8)

377

(32.0)

441

(30.4)

   Obese

525

(46.5)

538

(45.7)

797

(55.0)

   Missing

218

---

251

---

341

---

Comorbidities

      

   None

444

(33.0)

27

(1.9)

45

(2.5)

   1–2

570

(42.4)

628

(44.0)

837

(46.7)

   3–4

250

(18.6)

446

(31.2)

626

(35.0)

   5 or More

82

(6.1)

327

(22.9)

283

(15.8)

Avg # of Comorbidities

1.57 ± 1.62

 

3.12 ± 2.06

 

2.83 ± 1.73

 
  1. * All percentages are calculated for those with non-missing data. †All differences between characteristics for the insulin-managed and oral sulfonylurea managed groups were significant at the 0.02 level (p < 0.01). ‡ For the Body Mass Index(BMI) variable: underweight = BMI ≤ 18.5 kg/m2, normal = 18.6 < BMI < 25 kg/m2, overweight = 25.0 ≤ BMI < 30.0 kg/m2, and obese = BMI ≥ 30 kg/m2